TickerFacts.

Niagen Bioscience, Inc. (NAGE): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2018-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$607.0K
Year ended 2018-12-31
+28.5%
3-year compound annual growth
+19.8%
5-year compound annual growth
2013-12-28: $246.0K2015-01-03: $223.0K2016-01-02: $286.0K2016-12-31: $332.0K2017-12-30: $510.0K2018-12-31: $607.0K$607.0K
2013-12-28 Depreciation & Amortization (USD) 2018-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2018-12-31$607.0K+19.0%2019-03-07, From 2017-12-31
2017-12-30$510.0K+53.6%2019-03-07, From 2017-01-01
2016-12-31$332.0K+16.1%2018-03-15, From 2016-01-03
2016-01-02, Fiscal 2015$286.0K+28.3%2018-03-15, From 2015-01-04
2015-01-03, Fiscal 2014$223.0K-9.3%2017-03-16, From 2013-12-29
2013-12-28$246.0Kn/a2016-03-17, From 2012-12-30